According to the Zhitong Finance App, Hailey Biotech (603718.SH) revealed its 2022 annual report. The company achieved operating income of 300 million yuan during the reporting period, a year-on-year decrease of 13.62%. Net profit attributable to shareholders of listed companies was 122 million yuan, an increase of 125.80% over the previous year. Net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 248.14,400 yuan, an increase of 9.22% over the previous year. The basic earnings per share were 0.19 yuan/share. It is proposed to distribute a cash dividend of 0.567 yuan (tax included) for every 10 shares.
海利生物(603718.SH)发布2022年业绩 净利润1.22亿元 增长125.8% 每10派0.567元
Hailey Biotech (603718.SH) Announces 2022 Results Net Profit of 122 Million Yuan Increased by 125.8% to $0.567 per 10
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.